Risk-Based Approach to Foods Derived from Genetically Engineered Animals

Biological Concepts and Techniques in Toxicology: An Integrated Approach

Volumn , Issue , 2006, Pages 205-216

  Rudenko, Larisa ^a   Greenlees, Kevin J ^a   Matheson, John C ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36048960123     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Red-book 2000. Toxicological Principles for the Safety Assessment of Food Ingredients. July 2000, Updated October 2001, November 2003, and April 2004.
2. U.S. Food and Drug Administration Center for Veterinary Medicine. Guidance for Industry 3. General Principles for Evaluating the Safety of Compounds Used in Food Producing Animals, June 21, 2005.
3. U.S. Food and Drug Administration, Center for Veterinary, Veterinary International Commission on Harmonization (VICH). Medicine Guidance for Industry 149. Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Testing. Vich GL33, May 18, 2004.
4. World Health Organization. Environmental Health Criteria 70. Principles for the Safety Assessment of Food Additives and Contaminants in Food, 1987.
5. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Reg Toxicol Pharmacol 2000; 32:56-67.
6. U.S. Environmental Protection Agency. Epa/630/P-03/002A. External Review Draft. Framework for Application of Toxicity equivalence Methodology for Polychlorinated Dioxins, Furans, and Biphenyls in Ecological Risk Assessment, June 2003.
7. Jenness R. Composition of milk. In: Wong NP, Jenness R, Keeney M, Marth EH, eds. Fundamentals of Dairy Chemistry. New York: Van Nostrand Reinhold, 1988:1-38.
8. White SL, Bertrand JA, Wade MR, Washburn SP, Green JT, Jenkins TC. Comparison of fatty acid content of milk from Jersey and Holstein cows consuming pasture or a total mixed ration. J Dairy Sci 2001; 84:2295-2301.
9. Slikker W, Anderson ME, Bogdanffy MS, et al. Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol 2004; 201:203-225.
10. U.S. Food and Drug Administration Office of Food Additive Safety Guidance for Industry. Frequently Asked Questions About GRAS, November 2004.
11. U.S. Food and Drug Administration. Draft Guidance for Industry. Drugs Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals, 2002.
12. U.S. Food and Drug Administration. Draft Guidance for Industry. Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use. November 2004.
13. Codex Alimentarius Commission. Cac/GL44-2003. Principles for the Risk Analysis of Foods Derived From Modern Biotechnology, 2003.
14. Codex Alimentarius Commission. Draft Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants. Cac/GL45-2003.
15. Codex Alimentarius Commission. Guideline for the Conduct of Food Safety Assessment of Foods Produced Using Recombinant-DNA Microorganisms. Cac/GL 46-2003.
16. Brinster RL, Chen HY, Warren R, Sarthy A, Palmiter RD. Regulation of metallothio-nein-thymidine kinase fusion plasmids injected into mouse eggs. Nature 1982; 296(5852):39-42.
17. Palmiter RD, Brinster RL, Hammer RE, et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982; 300(5893):611-615.
18. Jacobson-Kram D, Sistaire FD, Jacobs AC. Use of transgenic mice in carcinogenicity hazard assessment. Toxicol Pathol 2004; 32(suppl 1):49-52.
19. MacDonald J, French JE, Gerson RJ, et al. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. Toxicol Sci 2004; 77:188-194.
20. Hammer RE, Pursel VG, Rexroad CE, et al. Nature 1985; 315(6021):680-683.
21. National Research Council. Risk Assessment in the Federal Government: Managing the Process. Washington, D.C.: National Academy Press, 1983.
22. National Research Council. Animal Biotechnology: Science-Based Concerns. Washington, D.C.: National Academy Press, 2002.
23. Barnes DG. Reference dose (RfD): description and use in health risk assessments. Reg Toxicol Pharmacol 1988; 8:471-486.
24. Food Additive Organization of the United Nations and World Health Organization. Summary evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA 1956-2003). Internet ed. Washington, D.C.: ILSI Press, 2004 (http://jecfa.ilsi.org).
25. Friedlander LG, Brynes SD, Fernandez AH. The human food safety evaluation of new animal drugs. Vet Clin N Am Food Anim Pract 1999; 15(1):1-11.
26. Wall R, Powell AM, Paape MJ, et al. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 2005; 23(4):445-451.
27. Rainard P. Tackling mastitis in dairy cows. Nat Biotechnol 2005; 23(4):430-432.
28. Codex Alimentarius, Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants (CAG1GL 45-2003): Annex. Assessment of Possible Allergenicity.
29. Brusic V, Petrovsky N, Gendel SM, Millot M, Gogonzac O, Stelman SJ. Computational tools for the study of allergens. Allergy 2003; 58:1083-1092.
30. Goodman RE, Hefle SL, Taylor SL, van Ree R. Assessing genetically modified crops to minimize the risk of increased food allergy: a review. Int Arch Allergy Immunol 2005; 137(2):151-152.
31. Helm RM, Burks AW. Animal models of food allergy. Curr Opin Allergy Clin Immunol 2002; 2(6):541-546.
32. Astwood JD, Leach JN, Fuchs RL. Stability of food allergens to digestion in-vitro. Nat Biotechnol 1996; 14(10):1269-1273.
33. US Food and Drug Administration, ‘‘Secondary Food Additives Permitted in Food for Human Consumption; Food Additives Permitted in Feed and Drinking Water of Animals; Aminoglycoside 3'-Phosphotransferase II; Final Rule. Federal Register 1994; 59:26, 700-26, 711.
34. Rudenko L, Matheson JC, Adams AL, Dubbin ES, Greenlees KJ. Food consumption risks associated with animal clones: what should be investigated? Cloning Stem Cells 2004; 6(2):79-93.
35. Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of ‘‘tox-icogenomics’’: impact of ‘‘-omics’’ technologies. Mutat Res 2002; 499:13-25.
36. Hamadeh HK, Bushel P, Paules R, Afshari CA. Discovery in toxicology: mediation by gene expression array technology. J Biochem Mol Toxicol 2001; 15(5):231-242.
37. Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? Mutat Res 2005; 575:102-115.
38. Waters MD, Olden K, Tennant RW. Toxicogenomic approach for assessing toxicant related disease. Mutat Res 2003; 544:415-424.